Literature DB >> 23416095

Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.

Inna G Ovsyannikova1, Iana H Haralambieva, Robert A Vierkant, Megan M O'Byrne, Gregory A Poland.   

Abstract

The role of polymorphisms within the antiviral tripartite motif (TRIM) genes in measles vaccine adaptive immune responses was examined. A limited association was found between TRIM5 (rs7122620) and TRIM25 (rs205499) gene polymorphisms and measles-specific antibody levels. However, many associations were found between TRIM gene SNPs and variations in cellular responses (IFN-γ Elispot and secreted cytokines IL-2, IL-6, IL-10, IFN-γ, and TNF-α). TRIM22 rs2291841 was significantly associated with an increased IFN-γ Elispot response (35 vs. 102 SFC per 2×10(5)PBMC, p=0.009, q=0.71) in Caucasians. A non-synonymous TRIM25 rs205498 (in LD with other SNPs, r(2)≥0.56), as well as the TRIM25 AAAGGAAAGGAGT haplotype, was associated with a decreased IFN-γ Elispot response (t-statistic -2.32, p=0.02) in African-Americans. We also identified polymorphisms in the TRIM5, TRIM22, and TRIM25 genes that were associated with significant differences in cytokine responses. Additional studies are necessary to replicate our findings and to examine the functional consequences of these associations.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23416095      PMCID: PMC3644318          DOI: 10.1016/j.humimm.2013.01.031

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  29 in total

1.  Twin studies of immunogenicity--determining the genetic contribution to vaccine failure.

Authors:  P L Tan; R M Jacobson; G A Poland; S J Jacobsen; V S Pankratz
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

2.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

3.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

4.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

5.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

6.  Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

7.  Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.

Authors:  Jenna E Ryan; Inna G Ovsyannikova; Gregory A Poland
Journal:  Methods Mol Biol       Date:  2005

Review 8.  TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.

Authors:  Markus G Grütter; Jeremy Luban
Journal:  Curr Opin Virol       Date:  2012-03-05       Impact factor: 7.090

9.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

Authors:  D F Fiorentino; A Zlotnik; P Vieira; T R Mosmann; M Howard; K W Moore; A O'Garra
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  19 in total

1.  Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay.

Authors:  Scott D Painter; Iana H Haralambieva; Inna G Ovsyannikova; Diane E Grill; Gregory A Poland
Journal:  Viral Immunol       Date:  2014-03       Impact factor: 2.257

2.  Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.

Authors:  Emily A Voigt; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Beth R Larrabee; Daniel J Schaid; Gregory A Poland
Journal:  Vaccine       Date:  2016-08-30       Impact factor: 3.641

3.  Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

4.  Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2015-09-02       Impact factor: 2.846

Review 5.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

Review 6.  The personal touch: strategies toward personalized vaccines and predicting immune responses to them.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Lambert; Iana H Haralambieva; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

7.  Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; Michael T Zimmermann; Diane E Grill; Daniel J Schaid; Gregory A Poland
Journal:  Hum Genet       Date:  2017-03-13       Impact factor: 5.881

8.  Heritability of vaccine-induced measles neutralizing antibody titers.

Authors:  Daniel J Schaid; Iana H Haralambieva; Beth R Larrabee; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 4.169

Review 9.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

10.  Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination.

Authors:  Iana H Haralambieva; Nathaniel D Lambert; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.